Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies

v3.19.1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

NOTE 10—COMMITMENTS AND CONTINGENCIES

Commitments

The Company is obligated under operating lease agreements covering the Company’s office facilities in Austin, Texas and Jersey City, New Jersey, respectively. Facilities expense under the operating leases was approximately $1.5 million and $625,000 thousand for the years ended December 31, 2018 and 2017, respectively.

Future minimum payments due under the operating lease agreements at December 31, 2018 were as follows (in thousands):

 

Year Ending December 31,

 

 

 

 

2019

 

$

1,266

 

2020

 

 

1,193

 

2021

 

 

1,222

 

2022

 

 

1,247

 

2023

 

 

499

 

Total

 

$

5,427

 

 

The Company leases laboratory equipment under non-cancelable capital lease agreements. As of December 31, 2018 and 2017, laboratory equipment under capital leases included in property and equipment totaled approximately $99,000 and $162,000, respectively, net of accumulated amortization of approximately $108,000 and $75,000, respectively. Future minimum capital lease payments consisted of the following at December 31, 2018 (in thousands):

 

Year Ending December 31,

 

 

 

 

2019

 

$

33

 

2020

 

 

21

 

Total future minimum capital lease payments

 

 

54

 

Less amount representing interest

 

 

(4

)

Total capital lease obligations

 

 

50

 

Current portion of lease obligations

 

 

(33

)

Capital lease obligations, non-current portion

 

$

17

 

 

 

Contingencies

In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by or on behalf of the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of its officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers and directors in certain circumstances. The Company maintains product liability insurance and comprehensive general liability insurance, which may cover certain liabilities arising from its indemnification obligations. It is not possible to determine the maximum potential amount of exposure under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular indemnification obligation. Such indemnification obligations may not be subject to maximum loss clauses. Management is not currently aware of any matters that could have a material adverse effect on the financial position, results of operations or cash flows of the Company.